Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The risk of chronic psychedelic and MDMA microdosing for valvular heart disease
Michael Tagen, Daniel Mantuani, Liron van Heerden, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 9, pp. 876-890
Closed Access | Times Cited: 20

Showing 20 citing articles:

Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access | Times Cited: 2
Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins
Antonin Rouaud, Abigail E. Calder, Gregor Hasler
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 217-224
Open Access | Times Cited: 13
Psychedelics in Psychiatry: Oh, What A Trip!
Gregory A. Fonzo, Charles B. Nemeroff, Ned H. Kalin
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 1-5
Closed Access | Times Cited: 1
Psilocybin: From Psychiatric Pariah to Perceived Panacea
Gregory A. Fonzo, Aaron Wolfgang, Bryan Barksdale, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 54-78
Closed Access | Times Cited: 1
Cardiovascular safety of psychedelic medicine: current status and future directions
Agnieszka Wsół
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1362-1380
Open Access | Times Cited: 20
Role of the gut–brain axis via the subdiaphragmatic vagus nerve in stress resilience of 3,4-methylenedioxymethamphetamine in mice exposed to chronic restrain stress
Youge Qu, Akifumi Eguchi, Li Ma, et al.
Neurobiology of Disease (2023) Vol. 189, pp. 106348-106348
Open Access | Times Cited: 17
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
Vince Polito, Paul Liknaitzky
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 701-711
Open Access | Times Cited: 4
State Cannabis and Psychedelic Legislation and Microdosing Interest in the US
Kevin H. Yang, Nora Satybaldiyeva, Matthew R. Allen, et al.
JAMA Health Forum (2024) Vol. 5, Iss. 6, pp. e241653-e241653
Open Access | Times Cited: 4
Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects
Carrie Cuttler, Amanda Stueber, Jonathan J. Simone, et al.
Journal of Psychoactive Drugs (2025), pp. 1-13
Closed Access
Treatment of neuropathic pain with repeated low-dose MDMA: a case report
Peter Gasser, Matthias E. Liechti, Friederike Holze
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Self-treatment with psychedelic substances for health and wellbeing in Aotearoa New Zealand: an exploratory descriptive study
Chris Arnison, Richard Egan, John H. Shaver
Kōtuitui New Zealand Journal of Social Sciences Online (2025), pp. 1-22
Open Access
Exploring Motivations, Experiences, and Consequences of Psychedelic Use in Aotearoa New Zealand
Ethan Mills, Jai Whelan, Sarah McGruddy, et al.
Journal of Psychoactive Drugs (2025), pp. 1-12
Open Access
Epigenetic mechanisms of rapid-acting antidepressants
Antonio Inserra, Antonella Campanale, Tamim Rezai, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Psychedelics and schizophrenia: a double-edged sword
Jacopo Sapienza, Francesca Martini, Stefano Comai, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 3
μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
Leah M. Salinsky, Christina R. Merritt, Joshua C. Zamora, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Effects of hallucinogenic drugs on the human heart
Joachim Neumann, Stefan Dhein, Uwe Kirchhefer, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Large language models auto-profile conscious awareness changes under psychedelic drug effects
Danilo Bzdok, Robin Carhart‐Harris, Chloé Savignac, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Electronic cigarettes are a tool to vape illicit drugs
Mariaelvina Sala
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access
Less is more? A review of psilocybin microdosing
Isabella A Savides, Kim Outhoff
Journal of Psychopharmacology (2024)
Closed Access
Small-Molecule Heterocyclic Compounds: Gq-Biased Agonists for the 5-HT2A Receptor in Neuropsychiatric Treatment
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 11, pp. 1498-1500
Open Access | Times Cited: 1
Page 1

Scroll to top